Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Archives Francaises De Pediatrie|December 1, 1989
[The accelerated phase of Chediak-Higashi syndrome]M Bejaoui, F Veber, D Girault, et al.Presse Medicale (Paris, France : 1983)|March 26, 1988
[Infection of the newborn infant by the human immunodeficiency virus]S Blanche, F Veber, C Rouzioux, et al.Clinical and Experimental Immunology|July 1, 1981
Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodiesS Berrih, C Gaud, M A Bach, et al.Revue Des Maladies Respiratoires|January 1, 1988
[Thymomas and associated diseases. Apropos of a series of 255 surgically treated thymomas]P Levasseur, M Menestrier, C Gaud, et al.Blood|July 1, 1989
Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiencyF Le Deist, S Blanche, H Keable, et al.Thrombosis and Haemostasis|March 11, 1998
Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(-1)) delivered for 10 days at therapeutic doseB Boneu, C Navarro, J P Cambus, et al.Immunologic Research|January 1, 1988
Cellular aspects of myasthenia gravisS Berrih-Aknin, S Cohen-Kaminsky, D Neumann, et al.Thrombosis and Haemostasis|July 10, 1998
Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)P Mismetti, S Laporte-Simitsidis, C Navarro, et al.BMC Immunology|October 1, 2016
Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trialJ F Viallard, P Agape, V Barlogis, et al.Pageof 2